• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体表心电图预测心脏再同步治疗候选者的结局:CARE-HF 试验的亚分析。

Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial.

机构信息

Département de Cardiologie, Centre Hospitalier Universitaire Pontchaillou, 35033 Rennes cedex 09, France.

出版信息

Eur J Heart Fail. 2009 Jul;11(7):699-705. doi: 10.1093/eurjhf/hfp074. Epub 2009 Jun 7.

DOI:10.1093/eurjhf/hfp074
PMID:19505883
Abstract

AIMS

In CARE-HF, cardiac resynchronization therapy (CRT) lowered morbidity and mortality in patients with moderate to severe heart failure. We examined whether baseline and follow-up electrocardiographic characteristics might predict long-term outcome.

METHODS AND RESULTS

CARE-HF randomly assigned 409 patients to medical therapy (MT) plus CRT, and 404 patients to MT alone. Electrocardiographic measurements were made at baseline during sinus rhythm, and at 3 months during paced or spontaneous rhythm depending on treatment assignment. Favourable outcome was defined as freedom from death, urgent transplantation, or cardiovascular hospitalization. Among patients assigned to CRT, 39% had unfavourable outcomes including 55 deaths. By single variable analysis, (i) prolonged PR interval, left QRS axis (but not QRS duration), and left bundle branch block (BBB) at baseline, and (ii) heart rate, PR, and QRS duration at 3 months predicted unfavourable outcome. By multiple variable analysis, treatment assignment (P = 0.0001), PR (P = 0.0004), and right BBB (P < 0.00013) at baseline predicted outcome, whereas baseline JTc and QRS duration at 3 months predicted all-cause mortality and heart failure hospitalization (P = 0.0071).

CONCLUSION

In CARE-HF, QRS duration at baseline did not predict outcome, but QRS at 3 months was a predictor by single variable analysis. Patients with prolonged PR interval and the 5% of patients with right BBB had a particularly high event rate.

摘要

目的

在 CARE-HF 研究中,心脏再同步治疗(CRT)降低了中重度心力衰竭患者的发病率和死亡率。我们研究了基线和随访心电图特征是否可以预测长期预后。

方法和结果

CARE-HF 研究将 409 例患者随机分为 CRT 加药物治疗(MT)组,404 例患者为 MT 组。在窦性心律时进行基线心电图测量,根据治疗分组,在起搏或自主节律时进行 3 个月的随访心电图测量。良好的预后定义为无死亡、紧急移植或心血管住院。在 CRT 组中,39%的患者出现不良预后,包括 55 例死亡。单变量分析显示,(i)基线时 PR 间期延长、左 QRS 轴(但不是 QRS 时限)和左束支传导阻滞(BBB),以及(ii)3 个月时的心率、PR 和 QRS 时限均预测不良预后。多变量分析显示,治疗分组(P = 0.0001)、基线时的 PR(P = 0.0004)和右 BBB(P < 0.00013)预测预后,而基线时的 JTc 和 3 个月时的 QRS 时限预测全因死亡率和心力衰竭住院率(P = 0.0071)。

结论

在 CARE-HF 研究中,基线 QRS 时限不预测预后,但 3 个月时的 QRS 时限是单变量分析的预测因素。PR 间期延长和 5%的患者存在右束支阻滞的患者事件发生率特别高。

相似文献

1
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial.体表心电图预测心脏再同步治疗候选者的结局:CARE-HF 试验的亚分析。
Eur J Heart Fail. 2009 Jul;11(7):699-705. doi: 10.1093/eurjhf/hfp074. Epub 2009 Jun 7.
2
Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.根据基线变量及早期反应预测心脏再同步治疗对死亡率的长期影响——来自CARE-HF(心力衰竭心脏再同步治疗)试验的报告
J Am Coll Cardiol. 2008 Aug 5;52(6):438-45. doi: 10.1016/j.jacc.2008.04.036.
3
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.糖尿病对晚期心力衰竭患者接受或未接受除颤器的心脏再同步治疗的影响。
J Card Fail. 2007 Nov;13(9):769-73. doi: 10.1016/j.cardfail.2007.06.723.
4
Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.心脏再同步治疗心力衰竭(CARE-HF)试验的长期死亡率。
Eur J Heart Fail. 2012 Jun;14(6):628-34. doi: 10.1093/eurjhf/hfs055. Epub 2012 May 2.
5
Cardiac resynchronization therapy: long-term alternative to cardiac transplantation?心脏再同步治疗:心脏移植的长期替代方案?
Ann Thorac Surg. 2009 Feb;87(2):432-8. doi: 10.1016/j.athoracsur.2008.09.071.
6
Heart failure: what proportion of patients satisfy the electrocardiographic criteria for cardiac resynchronization therapy?心力衰竭:符合心脏再同步治疗心电图标准的患者比例是多少?
Indian Heart J. 2003 Nov-Dec;55(6):619-23.
7
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.左心室不同步可预测心脏再同步治疗后的反应及预后。
J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40. doi: 10.1016/j.jacc.2004.08.016.
8
Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy.心电图模式与心脏再同步治疗的长期临床结局。
Europace. 2010 Feb;12(2):216-22. doi: 10.1093/europace/eup364. Epub 2009 Nov 14.
9
Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
Pacing Clin Electrophysiol. 2004 Nov;27(11):1513-8. doi: 10.1111/j.1540-8159.2004.00669.x.
10
Time intervals of cardiac resynchronization therapy in heart failure.心力衰竭患者心脏再同步治疗的时间间隔
Am J Cardiol. 2004 Nov 1;94(9):1192-6. doi: 10.1016/j.amjcard.2004.07.094.

引用本文的文献

1
Atrioventricular Node Dysfunction in Heart Failure: New Horizons from Pathophysiology to Therapeutic Perspectives.心力衰竭中的房室结功能障碍:从病理生理学到治疗前景的新视野
J Cardiovasc Dev Dis. 2025 Aug 15;12(8):310. doi: 10.3390/jcdd12080310.
2
Vectorcardiography in CRT: What We Know and What There Is to Learn.心脏再同步治疗中的向量心电图:我们所知道的与有待学习的内容。
J Cardiovasc Dev Dis. 2025 May 7;12(5):177. doi: 10.3390/jcdd12050177.
3
Quest for the ideal assessment of electrical ventricular dyssynchrony in cardiac resynchronization therapy.
心脏再同步治疗中心室电不同步理想评估方法的探索。
J Mol Cell Cardiol Plus. 2024 Jan 12;7:100061. doi: 10.1016/j.jmccpl.2024.100061. eCollection 2024 Mar.
4
The Atrioventricular Coupling in Heart Failure: Pathophysiological and Therapeutic Aspects.心力衰竭中的房室耦联:病理生理与治疗方面
Rev Cardiovasc Med. 2024 May 14;25(5):169. doi: 10.31083/j.rcm2505169. eCollection 2024 May.
5
Prognostic value of serum albumin in heart failure patients with cardiac resynchronization therapy.血清白蛋白对心力衰竭心脏再同步化治疗患者的预后价值。
Biomark Med. 2024;18(8):363-371. doi: 10.1080/17520363.2024.2347200. Epub 2024 May 24.
6
Ventricular dyssynchrony imaging, echocardiographic and clinical outcomes of left bundle branch pacing and biventricular pacing.左束支起搏与双心室起搏的心室不同步成像、超声心动图及临床结局
Indian Pacing Electrophysiol J. 2024 May-Jun;24(3):140-146. doi: 10.1016/j.ipej.2024.04.007. Epub 2024 Apr 22.
7
Frontiers in conduction system pacing: treatment of long PR in patients with heart failure.传导系统起搏前沿:心力衰竭患者长PR间期的治疗
Eur Heart J Suppl. 2023 Nov 9;25(Suppl G):G27-G32. doi: 10.1093/eurheartjsupp/suad116. eCollection 2023 Nov.
8
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023年美国心律学会/亚太心律学会/拉丁美洲心律学会关于避免和减轻心力衰竭的心脏生理性起搏指南。
J Arrhythm. 2023 Aug 2;39(5):681-756. doi: 10.1002/joa3.12872. eCollection 2023 Oct.
9
Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.心脏起搏和导联设备管理:EP Europace 杂志 25 年的研究成果。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad202.
10
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.2023 年 HRS/APHRS/LAHRS 心脏生理起搏指南:预防和减轻心力衰竭。
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.